BTMD logo

BIOTE CORP -A

BTMDNASDAQ
🏆 #4261 by market capEarnings Nov 4 · PostUS Equity
$1.20▲ $0.05 (+4.35%)
Latest quote
🔔
Track BTMD
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 4.3%
7d▲ 8.1%
14d▲ 7.6%
30d▼ 2.4%
ytd▼ 53.7%
1y▼ 55.1%
🏦Market Cap
$53M
Small Cap
📈Revenue Growth (YoY)
-2.5%
Declining
📊Gross Margin
60.2%
High
💵FCF Margin
10.7%
Healthy
⚖️P/S Ratio
0.3x
Cheap
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
$1.14 – $1.20
52-Week Range
$1.00 – $2.98
Volume (shares)
33,752
Avg Volume (shares)
—
Shares Outstanding
44.1M
Next Earnings
2026-11-04

Fundamentals Snapshot

Annual Revenue
$192M
Last Q Revenue
$44M
P/E Ratio
7.0
P/S Ratio
0.3x
EPS (TTM)
$0.20
Dividend Yield
0.00%
Dilution (1yr)
−17.3%
BTMD logo

BIOTE CORP -A

BTMD
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$192M▼ −2.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
71.5%▲ +1.3% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$36M▲ +12.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$30M▼ −22.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
30.8M▼ −17.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$86M▼ −$14M YoY
StockOtter · stockotter.space

About BIOTE CORP -A

Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100

Analyst Ratings

ⓘ
Consensus
Buy
11 analysts
Strong Buy3
Buy6
Hold2
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

Defense World·7d ago

Head-To-Head Survey: The Pennant Group (NASDAQ:PNTG) vs. biote (NASDAQ:BTMD)

biote (NASDAQ: BTMD - Get Free Report) and The Pennant Group (NASDAQ: PNTG - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the streng

Business Wire·7d ago

Biote Schedules Third Quarter 2026 Financial Results Release and Conference Call

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners' patients, t

Defense World·19d ago

biote (NASDAQ:BTMD) and Elevance Health (NYSE:ELV) Head to Head Review

Elevance Health (NYSE: ELV - Get Free Report) and biote (NASDAQ: BTMD - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their va

Seeking Alpha·Aug 6

biote Corp. (BTMD) Q2 2026 Earnings Call Transcript

biote Corp. (BTMD) Q2 2026 Earnings Call Transcript

Zacks Investment Research·Aug 5

biote Corp. (BTMD) Reports Break-Even Earnings for Q2

biote Corp. (BTMD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.1 per share a year ago.

MarketBeat·Aug 5

biote Q2 Earnings Call Highlights

biote NASDAQ: BTMD reported lower second-quarter revenue and a net loss as a voluntary recall of certain hormone pellets supplied by Asteria Health disrupted procedure volumes, while management said supply conditions hav